Medistim (MEDI)

[Savepig]

Medistim og Photocure uke for uke de siste årene.

Fint i healthcare!

[TekBot]

Fourth quarter results and preliminary financials for 2020 for Medistim ASA

Medistim invites you to a presentation of the fourth quarter results and preliminary financials for 2020 and status for the company. Because of the COVID-19 situation and the fact that Medistim has an increasing number of international investors, the fourth quarter results and preliminary financials will be presented through a webinar. The webinar takes place Friday the 26th of February and will start at 08.00 Norwegian time. The webinar will be available on Medistim website after the presentation. Representatives for the company will be: Kari Eian Krogstad - CEO Thomas Jakobsen - CFO To sign up to join the webinar please follow the link to register: https://attendee.gotowebinar.com/register/3958500658316518668
…

Vis børsmeldingen

Kilde

[Savepig]

Ny fin medistim-dag. Ikke så mye omtale skal sies

[TekBot]

4th quarter report and preliminary financials for 2020 for Medistim ASA

Sales for the quarter ended at MNOK 94.2 (MNOK 95.7), a decrease of 1.6%. Sales for 2020 ended at MNOK 363.1 (MNOK 363.7). Operating result (EBIT) for the quarter ended at MNOK 22.1 (MNOK 19.7) a 12.1% increase. Operating result the year 2020 ended at MNOK 95.5 (MNOK 89.8), a 6.4% increase. This is the best operating result for a year ever. Cashflow from operations was a solid MNOK 74.3. Cash by the end of the year was MNOK 71.9 after a dividend of MNOK 50.1 in November. Medistim has entered a Distribution agreement with LivaNova for India. The Board will suggest to the General Meeting a dividend of NOK 3.00 per share.
…

Vis børsmeldingen

Kilde

[Savepig]

@TekBot

This is the best operating result for a year ever.

Yeah it was

[tooeasy891]

SALVESEN & THAMS INVEST AS

solgte seg ut etter close på 246kr 10% av aksjene i selskapet.

[TekBot]

Salvesen & Thams Invest AS selger alle sine aksjer i Medistim ASA til Aeternum Capital AS

Salvesen & Thams Invest AS («S&T) har i dag solgt alle sine 1 862 500 aksjer i Medistim ASA til 246 kroner per aksje til Aeternum Capital AS. Aksjeposten utgjør 10,16% av aksjene i Medistim ASA, og har en samlet verdi på NOK 458 175 000.

S&T har vært eier i Medistim i mer enn ti år og har vært representert i styret med Bjørn Wiggen i 7 år. S&T er et investeringsselskap som forvalter omtrent NOK 2 mrd med hovedfokus på aktivt eierskap i privateide selskaper. Etter en meget god verdiutvikling de siste årene utgjorde Medistim en vesentlig post i porteføljen til S&T. Det er derfor et strategisk valg å selge seg ut av Medistim for å kunne gjøre flere nye investeringer i private selskaper hvor S&T kan bidra til vekst og utvikling.
…

Vis børsmeldingen

S&T er meget imponerte over utviklingen og posisjonen Medistim har tatt i sitt marked, og mener Aeternum Capital vil være en god og langsiktig eier som vil ønske å bidra til den videre utviklingen til selskapet.

Bjørn Wiggen er styreleder og eier av 19% av Salvesen & Thams Invest AS. Bjørn Wiggen er nestleder i styret i Medistim ASA.

For ytterligere informasjon kontakt:
Bjørn Wiggen, styreleder i Salvesen & Thams Invest AS,
Tlf. 478 20 937, eller
Per Olav Monseth, daglig leder i Salvesen & Thams Invest AS
Tlf. 924 06 889.

Kilde

[Hypergris]

@TekBot

Aeternum Capital

Overraskende og spennende

[Savepig]

Navnet sa meg ingenting, men holy crap. Her blir visst stafettpinnen levert videre fra en fantastisk eier til en ny en.

Stjerneforvalter for Fredriksen: Papirgevinster på nesten 1 milliard

" Aeternum skal være den aktive eieren som mange selskaper ønsker å ha – en som gir industriell input tilbake og som kan bidra til å fasilitere vekst innen nye produkter, tjenester og geografiske markeder, sier Vegard Søraunet, leder i Aeternum Capital"

[TekBot]

Flagging

Aeternum Capital AS har i dag kjøpt 1.862.500 aksjer i Medistim ASA og eier etter dette 1.862.500 aksjer i Medistim ASA. Dette representerer 10,16 % av aksjekapitalen.

For ytterligere informasjon kontakt Investeringsansvarlig Vegard Søraunet på telefon +47 91 33 44 30.
…

Vis børsmeldingen

Kilde

[Savepig]

Markedet liker det de ser, volatil fra dag til dag men trenden er temmelig klar

[TekBot]

Board approval of the 2020 Financial Statements for Medistim ASA

(Oslo, 19th of March 2021) Medistim ASA (OSE: MEDI), a niche market leader within ultrasound technology with headquarter in Norway, that develops and commercializes medical equipment for use within cardiac, vascular and transplant surgery, announces that the Board of Medistim ASA has approved the Financial Statements for 2020. The Financial Statements are without changes from the preliminary Financial Statements published on the 26th of February 2021. The Annual General Meeting will be held on 27th of April 2021.

About Medistim:
…

Vis børsmeldingen

Medistim was established in 1984, and has a track record of profitable growth over the past >15 years. The company is a pioneer within its segment, and continues to invest in new product development. Medistim has wholly owned subsidiaries with sales organizations in the USA, Germany, UK, Spain, Denmark and Norway, in addition to the about 50 distributors in Europe, Asia, Middle East, Africa, Canada and South America. For more information, visit the Medistim home page: www.Medistim.com

This information is disclosed under Norwegian law (Verdipapirhandelloven §5-12).
For more information, contact:

President and CEO, Kari E. Krogstad, Medistim ASA
Tel: + 47 918 38 110
Email: kari.krogstad@medistim.com

CFO, Thomas Jakobsen, Medistim ASA
Tel: + 47 906 59 940
Email: thomas.jakobsen@medistim.com

Kilde

[TekBot]

Medistim ASA - Flagging og meldepliktig handel

Oslo 25.03.2021

Det meddeles herved at Intertrade Shipping AS i dag har solgt 715.000 aksjer i Medistim ASA for NOK 252,- pr. aksje. Ny beholdning etter salget utgjør 1.285.000 aksjer.
…

Vis børsmeldingen

Som følge av salget reduserer Intertrade Shipping sin eierandel i Medistim ASA fra 10,9 % til 7 %.
Intertrade Shipping AS er eiet av familien Brøymer. Øyvin A. Brøymer er styreleder i Medistim ASA.

Kilde

[TekBot]

Notice of Annual General Meeting in Medistim ASA

(Oslo, 29th of March 2021) Medistim ASA (OSE: MEDI), a niche market leader within ultrasound technology with headquarters in Norway, that develops and commercializes medical equipment for use within cardiac, vascular and transplant surgery, announces the Annual General Meeting for the company.

The Annual General Meeting will take place on the 27th of April 2021 at 10.00 and is held at Medistim’s offices at Økernveien 94 in Oslo. Attached are the agenda for the meeting, the voting form and the annual report for 2020.
…

Vis børsmeldingen

Due to the coronavirus pandemic, a physical general meeting cannot be held. Instead, shareholders should authorize the Chairman of the Board. It is possible to give proxy with and without voting instructions. By using a proxy with voting instructions, the shareholders will vote on the specific issues without personal attendance. For further information on the use of proxy, see general information at the bottom of the notice and enclosed proxy forms.

Attached is also the annual report for 2020 for Medistim ASA. The report will also be available on the company web site: www.medistim.com.

About Medistim:
Medistim was established in 1984, and has a track record of profitable growth over the past >15 years. The company is a pioneer within its segment, and continues to invest in new product development. Medistim has wholly owned subsidiaries with sales organizations in the USA, Germany, UK, Spain, Denmark and Norway, in addition to the about 50 distributors in Europe, Asia, Middle East, Africa, Canada and South America. For more information, visit the Medistim home page: www.Medistim.com

This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act (Verdipapirhandelloven).

For more information, contact:
President and CEO, Kari E. Krogstad, Medistim ASA
Tel: + 47 918 38 110
Email: kari.krogstad@medistim.com

CFO, Thomas Jakobsen, Medistim ASA
Tel: + 47 906 59 940
Email: thomas.jakobsen@medistim.com

Kilde

[TekBot]

First quarter financials 2021 for Medistim ASA

Medistim invites you to a presentation of the first quarter financials for 2021 and status for the company. Because of the COVID-19 situation and the fact that Medistim has an increasing number of international investors, the first quarter financials and status will be presented through a webinar. The webinar takes place Wednesday the 28th of April and will start at 08.00 Norwegian time. The webinar will be available on Medistim website after the presentation. Representatives for the company will be:
Kari Eian Krogstad - CEO Thomas Jakobsen - CFO

…

Vis børsmeldingen

To sign up to join the webinar please follow the link to register: https://register.gotowebinar.com/register/1205026675595200525

Kilde

[TekBot]

Disclosure of voting rights

Øyvin Brøymer, Chairman of Medistim ASA, has received authorization for a total of 5,210,398 voting shares in connection with the Annual General Meeting in Medistim ASA the 27th of April 2021. This represents 28.41 % of voting shares. Along with Brøymers shares through Intertrade Shipping AS that has 1,285,000 shares, Brøymer votes for a total of 6,495,398 shares. This represents 35.42 % of the voting shares. The authorizations are valid for the Annual General Meeting in Medistim ASA the 27th of April 2021.
…

Vis børsmeldingen

Kilde

[TekBot]

The General Meeting in Medistim ASA decided a dividend of NOK 3.00 per share

Oslo, the 27th of April 2021. The votes from the General Meeting today in Medistim ASA, has resolved to distribute a dividend of NOK 3.00 per share based on the Company’s net profit for the 2020 financial year. The total dividend will amount to NOK 54.65 million, which corresponds to 78.7% of the net profit for 2020. The dividend will be payable to the shareholders of the Company as of the 27th of April 2021, as registered in the Company’s shareholder register in the VPS on the 29th of April 2021 (the record date). The shares will be traded exclusive of the right to dividends from and including the 28th of April 2021 (ex-date). The dividend will be distributed the 7th of May 2021.
…

Vis børsmeldingen

Kilde

[TekBot]

Protocol from General Meeting in Medistim ASA

Attached is the protocol from the General Meeting in Medistim ASA the 27th of April 2021.
…

Vis børsmeldingen

Kilde

[TekBot]

Interim report for Medistim ASA and results for the first quarter 2021

Sales for the quarter ended at MNOK 102.6 (MNOK 103.1), on par with the sales record set in Q1 last year. Currency neutral, sales increased by 1.5%. Second best quarter ever for operating result (EBIT) at MNOK 29.0 (MNOK 24.8), an increase of 17.3% over last year. EBIT margin was 28.3%. Medistim partners with LivaNova as distributor for India. The General Assembly decided to pay a dividend of NOK 3.00 per share.
…

Vis børsmeldingen

Kilde

[TekBot]

Ex dividend NOK 3.00 today

The shares in Medistim ASA will be traded ex dividend NOK 3.00 as from today, 28.04.2021.
…

Vis børsmeldingen

Kilde